Combination of BMS-986205 and nivolumab shows early promise in phase I/IIa study.
from Cancer via ola Kala on Inoreader http://ift.tt/2jgHKC2
via IFTTT
Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου